This inventor holds 49 USPTO granted patents and 1 published patent application, primarily in Neurodegenerative Disorders. Top assignees: Pfizer Corporation, Eisai Company, Limited, Pfizer Products Inc.. Active years: 1988-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Groton, CT (US) (1989 - 1991)
- Waterford, CT (US) (1988 - 2010)
Company Filing History:
45 out of 4,488 
1 out of 677 
1 out of 47 
Years Active: 1988-2010
Areas of Expertise:
Title: Innovator Spotlight: Yuhpyng Liang Chen, Pioneering Researcher in Neurological Disorder Treatments
Introduction: Yuhpyng Liang Chen, a distinguished inventor from Waterford, CT, has made significant contributions to the field of pharmaceuticals, specializing in the development of treatments for neurological disorders. With an impressive portfolio of 49 patents, Chen is renowned for his groundbreaking work in the area of neurodegenerative diseases, particularly Alzheimer's disease.
Latest Patents: Among his recent innovations are two groundbreaking patents. The first patent involves the development of Imidazole compounds for the treatment of neurological disorders. These compounds have shown promise in inhibiting the production of Aβ-peptide, a hallmark of Alzheimer's disease. The second patent focuses on Pyrazole compounds for the treatment of neurodegenerative disorders, demonstrating similar potential in combating Alzheimer's disease.
Career Highlights: Yuhpyng Liang Chen has a rich professional background, having worked with prominent pharmaceutical companies such as Pfizer Corporation. His expertise and relentless pursuit of innovative solutions have positioned him as a key figure in the pharmaceutical industry, particularly in the realm of neurological disorder treatments.
Collaborations: Throughout his career, Chen has collaborated closely with esteemed colleagues such as Arthur A Nagel and Anabella Villalobos. These collaborative efforts have led to the development of groundbreaking treatments and have enhanced the understanding of neurological disorders.
Conclusion: In conclusion, Yuhpyng Liang Chen's unwavering dedication to advancing pharmaceutical research has propelled him to the forefront of innovation in the treatment of neurological disorders. His prolific career, marked by numerous patents and impactful collaborations, underscores his commitment to improving healthcare outcomes for patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile